Experimental drug could prevent cancer DNA repair to boost radiotherapy effects

Treating bladder and head-and-neck cancers with an experimental drug called CCT244747 makes radiotherapy more successful at killing them, scientists have discovered. The research could pave the way for more effective treatment for these diseases. A new study led by Professor Kevin HarringtonĀ and Dr Shane Zaidi of The Institute of Cancer Research, London, showed that pre-treating cancerous cells with the compound led to more cells dying following radiotherapy.